PGIM Jennison Health Sciences Fund- Class A
PHLAX
NASDAQ
| Weiss Ratings | PHLAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C+ | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | PHLAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | PGIM | |||
| Manager/Tenure (Years) | Debra Netschert (11), Daniel Matviyenko (5) | |||
| Website | http://pgim.com/investments | |||
| Fund Information | PHLAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | PGIM Jennison Health Sciences Fund- Class A | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Jun 30, 1999 | |||
| Open/Closed To New Investors | Closed | |||
| Minimum Initial Investment | 1,000.00 | |||
| Minimum Subsequent Investment | 100.00 | |||
| Front End Fee | 0.06 | |||
| Back End Fee | -- | |||
| Dividends and Shares | PHLAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.10% | |||
| Dividend | PHLAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.67% | |||
| Asset Allocation | PHLAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 7.14% | |||
| Stock | 92.86% | |||
| U.S. Stock | 86.10% | |||
| Non-U.S. Stock | 6.76% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | PHLAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.36% | |||
| 30-Day Total Return | -3.99% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | -0.78% | |||
| Year to Date Total Return | 7.10% | |||
| 1-Year Total Return | 24.94% | |||
| 2-Year Total Return | 18.64% | |||
| 3-Year Total Return | 53.03% | |||
| 5-Year Total Return | 42.93% | |||
| Price | PHLAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | PHLAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $37.97 | |||
| 1-Month Low NAV | $37.92 | |||
| 1-Month High NAV | $39.90 | |||
| 52-Week Low NAV | $32.05 | |||
| 52-Week Low NAV (Date) | Mar 27, 2026 | |||
| 52-Week High NAV | $41.48 | |||
| 52-Week High Price (Date) | Nov 26, 2025 | |||
| Beta / Standard Deviation | PHLAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.58 | |||
| Standard Deviation | 15.52 | |||
| Balance Sheet | PHLAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 1.50B | |||
| Operating Ratios | PHLAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.15% | |||
| Turnover Ratio | 81.00% | |||
| Performance | PHLAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 24.15% | |||
| Last Bear Market Total Return | -9.41% | |||